Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EarClear is an Australian brand of over-the-counter (OTC) ear care products developed and distributed by Key Pharmaceuticals. The brand encompasses a range of topical solutions and medical devices designed to manage common ear health issues, including ear wax impaction, earaches, and swimmer's ear (otitis externa). The product line includes EarClear Ear Wax Remover, which typically utilizes carbamide peroxide or pharmaceutical-grade olive oil to soften and facilitate the removal of cerumen, and EarClear Ear Ache Relief, which combines the analgesic phenazone with the local anesthetic benzocaine for symptomatic pain relief. Additionally, the brand provides specialized solutions for drying the ear canal and medical devices such as ear syringes with tri-stream tips for safe irrigation. These products are approved for sale in Australia and are marketed for use in both adults and children.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on EarClear.